1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice
  1. Anonymous

    Anonymous Guest

    As a tech with this company, I can't warn future prospects enough. I was lied to from the beginning. I am using this job as a paycheck while I continue to interview.